INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis

RTTNews | 1480 hari yang lalu
INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For  Respiratory Papillomatosis

(RTTNews) - Biotechnology company Inovio Pharmaceuticals Inc. (INO) announced Thursday positive interim results from an ongoing Phase 1/2 clinical trial evaluating INO-3107 for the treatment of HPV 6 and HPV 11-associated Recurrent Respiratory Papillomatosis (RRP) in adults.

In the first cohort of 21 participants, INO-3107 showed a statistically significant improvement in the clinical endpoint of the number of surgical interventions needed to control papilloma growth.

INO-3107 was also observed to be well-tolerated and immunogenic in the trial. INO-3107 received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) in July 2020.

INO-3107 was evaluated in a Phase 1/2 open-label, multicenter trial to assess its safety, tolerability, immunogenicity, and efficacy in 32 participants with HPV 6 and/or HPV 11-associated RRP.

Results from the second cohort of 11 patients are expected in the first half of 2023.

For More Such Health News, visit rttnews.com

baca selengkapnya
Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a BLA for review under the FDA's accelerated approval program.
RTTNews | 1118 hari yang lalu
Swiss Market Ends Modestly Higher

Swiss Market Ends Modestly Higher

The Switzerland market's benchmark SMI ended modestly higher on Friday after holding firm throughout the trading session, outperforming most of its peers in Europe.
RTTNews | 1 hari yang lalu
Major European Markets End Mixed As Investors React To Earnings, Economic Data

Major European Markets End Mixed As Investors React To Earnings, Economic Data

The major European markets closed mixed on Friday even as most of the other markets across the continent ended notably lower, as investors reacted to a slew of corporate earnings announcements and the latest batch of regional economic data. Higher oil prices and weakness in the tech sector due to renewed uncertainty about returns on AI-related investments hurt sentiment.
RTTNews | 1 hari yang lalu